drugset / Trial / NCT00711386

GSK706769 Repeat Dose Study

NCT00711386

Phase 1 Completed 40 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

To determine safety, tolerability and Pharmacokinetics of GSK706769

Timeline

Start
2008-05-16
Primary completion
2008-09-12
Completion
2008-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK706769 Unknown 50 mg
Subject GSK706769 Unknown 100 mg
Subject GSK706769 Unknown 200 mg
Subject GSK706769 Unknown 400 mg